Skip to content

Clinical trials

Phase 2 Parkinsonian Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Phase: Phase 2 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20063
20081
20101
20111
20122
20171
20211
20233
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Recruiting2
Unknown status1
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute for Neurodegenerative Disorders6
Novartis Pharmaceuticals3
Akiva Mintz1
Bial R&D Investments, S.A.1
Biocells Medical1
Centre Hospitalier Universitaire de Nice1
Chang Gung Memorial Hospital1
Fujian Medical University Union Hospital1
GE Healthcare1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders22
Parkinson Disease13
Movement Disorders8
Disease5
Neurodegenerative Diseases5
Central Nervous System Diseases4
Basal Ganglia Diseases3
Brain Diseases3
Dyskinesias3
Nervous System Diseases3

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.